mequitazine has been researched along with Chronic Illness in 2 studies
mequitazine: RN given refers to parent cpd without isomeric designation; structure
Excerpt | Relevance | Reference |
---|---|---|
"A new type of antiallergic drug, oxatomide (60 mg daily), was compared with the antihistaminic, mequitazine (10 mg daily), in a 5-week double-blind randomized study involving 26 patients with chronic urticaria." | 9.05 | Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. ( Broux, R; Demaubeuge, J; Tennstedt, D, 1982) |
"A new type of antiallergic drug, oxatomide (60 mg daily), was compared with the antihistaminic, mequitazine (10 mg daily), in a 5-week double-blind randomized study involving 26 patients with chronic urticaria." | 5.05 | Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. ( Broux, R; Demaubeuge, J; Tennstedt, D, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demaubeuge, J | 1 |
Tennstedt, D | 1 |
Broux, R | 1 |
Harto, A | 1 |
Sendagorta, E | 1 |
Ledo, A | 1 |
2 trials available for mequitazine and Chronic Illness
Article | Year |
---|---|
Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine.
Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists; Hum | 1982 |
Doxepin in the treatment of chronic urticaria.
Topics: Adolescent; Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Doxepin; Female; | 1985 |